{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:58:48Z","timestamp":1790632728566,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/iae.0000000000000614","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T11:45:00Z","timestamp":1432813500000},"page":"2505-2515","source":"Crossref","is-referenced-by-count":119,"title":["SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"35","author":[{"given":"Elodie","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Rapha\u00ebl","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Brandely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Couraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gaudric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":". The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":". Central serous chorioretinopathy.","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology.","volume":"141","author":"Liew","year":"2013","journal-title":"Clin Experiment Ophthalmol"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":". Central serous chorioretinopathy in younger and older adults.","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.08-1779","article-title":". In vivo human choroidal thickness measurements: evidence for diurnal fluctuations.","volume":"50","author":"Brown","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy.","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R7-9-20210130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/eye.2011.258","article-title":"Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.","volume":"25","author":"Kim","year":"2011","journal-title":"Eye (Lond)"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":". Indocyanine green videoangiography of older patients with central serous chorioretinopathy.","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00006982-199919060-00005","article-title":"Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.","volume":"19","author":"Iida","year":"1999","journal-title":"Retina"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids.","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":". Risk factors for central serous chorioretinopathy: a case-control study.","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":". Systemic findings associated with central serous chorioretinopathy.","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":". The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells.","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":". Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":". Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":". Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2885.2009.01130.x","article-title":"A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog.","volume":"33","author":"Guyonnet","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00542109","article-title":"Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man.","volume":"25","author":"Krause","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1167\/iovs.12-9868","article-title":"A novel technique of adjusting segmentation boundary layers to achieve comparability of retinal thickness and volumes between spectral domain and time domain optical coherence tomography.","volume":"53","author":"Tan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","article-title":"A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes.","volume":"147","author":"Margolis","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":". Finasteride for chronic central serous chorioretinopathy.","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"key":"R25-9-20210130","first-page":"99","article-title":". The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy.","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Mol Vis"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy.","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"key":"R27-9-20210130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1552-4604.1989.tb03339.x","article-title":". Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites.","volume":"29","author":"Gardiner","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"R28-9-20210130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11883-013-0340-x","article-title":"Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.","volume":"15","author":"McGraw","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCHEARTFAILURE.113.000530","article-title":". Race influences the safety and efficacy of spironolactone in severe heart failure.","volume":"6","author":"Vardeny","year":"2013","journal-title":"Circ Heart Fail"},{"key":"R30-9-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0031-1299774","article-title":". Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.","volume":"44","author":"Michaelis","year":"2012","journal-title":"Horm Metab Res"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:52:01Z","timestamp":1748404321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201512000-00009"}},"subtitle":["A Randomized Controlled Crossover Study"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000614","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}